| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nuo Therapeutics, Inc. (AURX) has 6 insiders with recent SEC Form 4 filings, including 8 buys and 7 sells. AURX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 11.57M | $14.46M | - | |
| 10% | 5.40M | $6.75M | - | |
| CEO | 2.07M | $2.59M | - | |
| COO | 770.1K | $962.6K | - | |
| Dir | 108.3K | $135.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2017 | Sheedy Charles E | 10% Owner | Buy | 5,220,000 | $0.22 | $1,159,884.00 | +170.2% | |
| Aug 10, 2017 | Pittman Scott M. | Director, 10% Owner | Buy | 2,045,000 | $0.30 | $609,967.00 | +62.6% | |
| May 5, 2016 | Del Guercio Joseph | Director | Buy | 250,000 | $1.00 | $250,000.00 | New | |
| May 5, 2016 | Pittman Scott M. | Director | Buy | 825,000 | $1.00 | $825,000.00 | +275.0% | |
| May 5, 2016 | Jorden David Emerson | CEO And CFO | Buy | 137,500 | $1.00 | $137,500.00 | New | |
| May 5, 2016 | Winzer C Eric | Director | Buy | 25,000 | $1.00 | $25,000.00 | New | |
| May 11, 2015 | Aldagen Holdings, LLC | 10% Owner, May Be Part Of A 13(d) Group | Sell | 50,000 | $0.27 | $13,500.00 | -0.4% | |
| Jan 20, 2015 | Aldagen Holdings, LLC | 10% Owner, May Be Part Of A 13(d) Group | Sell | 5,500 | $0.35 | $1,925.00 | - | |
| Jan 14, 2015 | Aldagen Holdings, LLC | 10% Owner, May Be Part Of A 13(d) Group | Sell | 167,467 | $0.35 | $58,613.45 | -0.7% | |
| Jan 12, 2015 | Aldagen Holdings, LLC | 10% Owner, May Be A Part Of A 13(d) Group | Sell | 217,383 | $0.35 | $76,084.05 | -0.6% |